Bacteriophage ΦSA012 Has a Broad Host Range against Staphylococcus aureus and Effective Lytic Capacity in a Mouse Mastitis ModelHidetomo Iwano, Yutaka Tamura, Katsuro Hagiwara et al.|Biology|2018Cited by 67
Phage Therapy Is Effective in a Mouse Model of Bacterial Equine KeratitisTakaaki Furusawa, Yutaka Tamura, Hidetomo Iwano et al.|Applied and Environmental Microbiology|2016Cited by 62
Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent Staphylococcus aureus BacteriophageJumpei Fujiki, Hidetomo Iwano, Tomohiro Nakamura et al.|Pharmaceuticals|2018Cited by 39
Biological properties of Staphylococcus virus ΦSA012 for phage therapyJumpei Fujiki, Hidetomo Iwano, Tomohiro Nakamura et al.|Scientific Reports|2022Cited by 26
Analysis host-recognition mechanism of staphylococcal kayvirus ɸSA039 reveals a novel strategy that protects Staphylococcus aureus against infection by Staphylococcus pseudintermedius Siphoviridae phagesAa Haeruman Azam, Yasunori Tanji, Kenji Kadoi et al.|Applied Microbiology and Biotechnology|2019Cited by 21